Hepatitis, Chronic: all 829 studies
Page 7 of 9. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.
- GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC GenotypeTerminatedNCT01384383Phase 2
- Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)Status unknownNCT01380951Phase 4
- Different Ribavirin Dosages and Different Duration of Treatment in Combination With PegInterferon in Patients With Genotype 2 and 3 (WRITE)CompletedNCT01380938Phase 3
- HCV Treatment With Fluvastatin, Simvastatin to Improve Interferon SensitivityTerminatedNCT01377909Phase 1
- NASVAC Phase-III Trial in Chronic Hepatitis B (CHB) PatientsStatus unknownNCT01374308Phase 3
- PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B PatientsCompletedNCT01373684Phase 4
- Prediction of Incidence of Liver Cancer by Use of Real-time Tissue ElastographyStatus unknownNCT01360892
- Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver DiseaseStatus unknownNCT01360879
- Efficacy of Medical Ozone Therapy in Patients With Chronic Hepatitis BStatus unknownNCT01342185Phase 3
- Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC TherapyStatus unknownNCT01341743Phase 4
- Induction of Fibrosis Regression on Patients With Chronic Hepatitis B InfectionTerminatedNCT01341106Phase 4
- Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase LevelsCompletedNCT01337791Phase 4
- CHRONVAC-C Study Followed by Standard of Care in Chronic Hepatitis C Virus (HCV) SubjectsStatus unknownNCT01335711Phase 2
- Entecavir for Chronic Hepatitis BCompletedNCT01323452
- Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis BCompletedNCT01311947
- Extension Study SCI-SCV-HCV-P2-001: Long-Term FU in Subj Who Opt for Retreatment With Peg-INF and RBV After Completing Treatment in HCVCompletedNCT01310205
- Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C PatientsCompletedNCT01290965Phase 1
- Vitamin D Deficiency in Subjects With Chronic Hepatitis C Compared to Healthy VolunteersWithdrawnNCT01274013
- Clinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy.Status unknownNCT01272310Phase 1/2
- Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation TherapyStatus unknownNCT01270178
- Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis BStatus unknownNCT01270165Phase 3
- A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV PatientsTerminatedNCT01266005Phase 4
- A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)CompletedNCT01264367Phase 4
- An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis BCompletedNCT01264354Phase 4
- A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis BTerminatedNCT01264133Phase 4
- An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related Symptom of Chronic Hepatitis B Patients Who Received ClevudineCompletedNCT01264107
- A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long PeriodTerminatedNCT01264094Phase 4
- Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B PatientsWithdrawnNCT01260610Not applicable
- Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis BStatus unknownNCT01243281Not applicable
- Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis BStatus unknownNCT01242787Phase 2
- A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis CCompletedNCT01225380Phase 2
- A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B InfectionTerminatedNCT01217632Phase 2
- Follow Up of Patients Chronic Hepatitis B (CHB) Treated With Sebivo Using the 13C Methacetin Breath TestWithdrawnNCT01204827Phase 2/3
- Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.CompletedNCT01195181Phase 4
- An Study of Efficacy and Safety of ClevudineCompletedNCT01192854Phase 3
- A Clinical Study on Therapeutic Double-plasmid Hepatitis B Virus (HBV) DNA Vaccine in Patients With HBeAg-positive Chronic Hepatitis BStatus unknownNCT01189656Phase 2
- Thymosin Alpha-1 in Combination With Peg-Interferon Alfa- 2a and Ribavirin for the Therapy of Chronic Hepatitis C Nonresponsive to the Combination of IFN and Ribavirin.CompletedNCT01178996Phase 3
- Exploration of Chronic Hepatitis C Infection Receiving 24-week Interferon-α With Ribavirin TreatmentsStatus unknownNCT01178749
- A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis BStatus unknownNCT01172392Phase 3
- Epidemiological Study in Children and Adolescents With Chronic Hepatitis BCompletedNCT01163240
- Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?CompletedNCT01159613
- Does 3 Months Therapy With Vitamin D + Peg + Ribavirin Improve Sustained Virologic Response (SVR) in Genotype 2, 3 Chronic Hepatitis C Patients?Status unknownNCT01151397Not applicable
- Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B PatientsStatus unknownNCT01148576Phase 4
- Study of VX-985 in Subjects With Chronic Hepatitis CCompletedNCT01144936Phase 1
- Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis BCompletedNCT01143662Phase 2
- A Study of BMS-824393 in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment Naive Subjects With Chronic Hepatitis C Virus Genotype IWithdrawnNCT01142700Phase 2
- Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis CCompletedNCT01140997Phase 2
- A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis CCompletedNCT01121731Phase 1/2
- Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid PharmacotherapyCompletedNCT01120795Phase 4
- Acoustic Radiation Force Impulse-Imaging in Comparison to Transient Elastography for Liver Fibrosis Staging in HCVCompletedNCT01113814Not applicable
- Chronic Hepatitis C (CHC) - Genotype 3 Infection in CanadaTerminatedNCT01100749
- Host Responses in Kidney-transplant Recipients With Chronic Hepatitis E Virus InfectionCompletedNCT01090232Not applicable
- Efficacy Optimizing Research of Lamivudine TherapyCompletedNCT01088009Phase 4
- A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus InfectionTerminatedNCT01080222Phase 2
- Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) PatientsWithdrawnNCT01062659
- PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)Status unknownNCT01056172Phase 4
- Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine TherapyCompletedNCT01037166Phase 2
- An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B InfectionCompletedNCT01037062Phase 2
- Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected PatientsStatus unknownNCT01027065Phase 1/2
- Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis BCompletedNCT01026610Phase 2
- The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus RibavirinStatus unknownNCT01025765Phase 4
- A Phase II Dose Response Study in Japan in Chronic Hepatitis BCompletedNCT01022801Phase 2
- A Study in Japan of the Safety and Antiviral Activity With Chronic Hepatitis B InfectionCompletedNCT01020565Phase 2
- Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of CareCompletedNCT01012895Phase 2
- Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin (MK-2355-004)CompletedNCT01011166Phase 2
- Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With TelbivudineTerminatedNCT01005238Phase 4
- Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected PatientsCompletedNCT00983060Phase 2
- Continue Entecavir Rollover From ChinaCompletedNCT00975091Phase 3
- Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic HepatitisCompletedNCT00973817Phase 2/3
- Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral LoadCompletedNCT00973219Not applicable
- Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have RelapsedCompletedNCT00968357Phase 2
- Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection SubjectsTerminatedNCT00964665Phase 1/2
- Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Chronic Hepatitis C Genotype I InfectionTerminatedNCT00962936Phase 1/2
- High Dose Ribavirin in the Treatment of Chronic Hepatitis CCompletedNCT00944684Phase 2
- Efficacy and Safety Study of Telbivudine to Prevent Perinatal TransmissionStatus unknownNCT00939068Phase 4
- Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin ResistanceTerminatedNCT00927290Phase 3
- Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 SubjectsCompletedNCT00926016Not applicable
- A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore AreaCompletedNCT00913757
- Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV TreatmentCompletedNCT00909129Not applicable
- Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis BCompletedNCT00907894Phase 1
- Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis BCompletedNCT00895596Phase 1/2
- PEG-IFN in HBV Patients With Incomplete Response to NACompletedNCT00883844Phase 4
- Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/RelapsersTerminatedNCT00882193Early Phase 1
- Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant PatientsCompletedNCT00881582Phase 4
- Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis BCompletedNCT00877760Phase 4
- Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis BCompletedNCT00877149Phase 4
- Effects of Genotypes on Interferon Signaling in Chronic Hepatitis CWithdrawnNCT00876174
- Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 WeeksWithdrawnNCT00862706Phase 4
- A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis BCompletedNCT00857675Phase 3
- A Study of Debio 025 (Alisporivir) Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 PatientsCompletedNCT00854802Not applicable
- Psychoeducation Reaches HCV-infected Methadone/Buprenorphine Substituted Patients in Standard Antiviral TreatmentCompletedNCT00844272Phase 4
- Efficacy of Long-term Ribavirin in Non-responders With Chronic Hepatitis C and Advanced FibrosisTerminatedNCT00840489Phase 2
- Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular CarcinomaStatus unknownNCT00834860Phase 4
- High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3CompletedNCT00830609Phase 4
- Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123)CompletedNCT00828269Phase 1
- Safety Study of SD-101 (a Novel C Type Toll-like Receptor 9 (TLR9) Agonist) for the Treatment of Chronic Hepatitis C Virus (HCV) InfectionCompletedNCT00823862Phase 1
- A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis BStatus unknownNCT00815464Not applicable
- Vitamin D Treatment in Patients With Chronic Hepatitis CStatus unknownNCT00804752Not applicable
- Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)CompletedNCT00804622Phase 2
- Study of Safety and Tolerability of Multiple Intravenous Doses of ANZ-521 in Adults With Chronic Hepatitis C VirusTerminatedNCT00800007Phase 1/2